Life Enhancing Medications

As an emerging specialty pharmaceutical company, Pangea Pharmaceuticals, leverages its proven expertise to advance its portfolio of therapeutics and comprehensive support services, all designed to deliver meaningful outcomes for patients.

Learn More
Pangea Pharmaceuticals

ABOUT US

Pangea Pharmaceuticals

Pangea has a strong commitment to patients by creating access to enhanced, safe, and more affordable medicines. In our effort to improve patient access to life-enhancing prescription medications, we offer a robust portfolio of branded and generic drugs for the pediatric health, pain management, neurological, and ophthalmic segments.

Biz Dev

We are constantly evaluating product opportunities to add to our commercial portfolio and late stage product development candidates across various therapeutic categories and dosage forms.

Our Focus

Our focus is to establish meaningful distribution relationships with hospitals, clinics, independent and specialty pharmacies, GPOs, and niche and speciality distributors.

Our Team

Decades of experience in the US pharmaceutical market provides an unparalleled experience to our partners and access to our global sourcing network of API and Contract Manufacturing partners.

Our Advantage

As a US-based specialty pharmaceutical company our streamlined structure promotes decisive action and a rapid go-to-market strategy for our products and partners.

48yrs

Combined Experience

With our combined experience, we bring a wealth of knowledge, expertise, and innovation to deliver exceptional results for our clients

6+

Pharmaceutical Products

Our pharmaceutical offerings are crafted with the highest standards of quality and safety, ensuring effective and reliable solutions for your health and well-being

12+

In Development

Our pharmaceutical products in development are designed to meet current and emerging patient needs as well as bridge gaps in the market

PRODUCT SPOTLIGHT

Ergomar Sublingual Tablets

Ergomar® (Ergotamine) is an ergot medication that treats certain types of headaches, including cluster headaches and migraines by tightening blood vessels and calming certain parts of the brain to relieve headache pain.

Strategic Aquisition

The acquisition of Ergomar has allowed us to optimize every aspect of the product lifecycle, making improvements from operations to distribution.

Visit Site

Pharmaceutical Migrane Prevention Product Spotlight
Pangea Pharmaceuticals Product Pipeline
SPECIALTY PHARMACEUTICAL

Core Strengths

Pangea's core strengths and our unwavering commitment to delivering high-quality specialty medications with precision and reliability

  • Life Enhancing Medicines
  • Leveraging Market Opportunities
  • Aquisitions & Licensing
  • Brand Development and Marketing
Pharmaceutical Partnerships
Partners

Pharmaceutical Partnerships

Pangea boasts strong distribution relationships with US retail chains, wholesalers, distributors, managed care organizations, mail order pharmacies, and Group Purchasing Organizations (GPOs).

Our robust commercial infrastructure, extensive experience, diverse distribution network, and our ability to execute efficient launches facilitate strategic business alliances and focused collaborations with other specialty pharmaceutical organizations. Please direct partnership inquiries to our commerical team.

Products

On Market Category Type
Ergomar Migraine Relief Commercial
Florafol Pediatric Vitamin Commercial
Florafol FE Pediatric Vitamin Commercial
Selenious Acid Injection IV Supplement Commercial
Phenobarbital Sodium Injection Barbiturate Partner
Tetracaine HCl Injection Neuronal Membrane Stabilizer Partner
Diclofenac Potassium Tablet NSAID Partner
Cataflam Pain Relief Partner
Lofena NSAID Partner
Papaverine Injection ED Partner
IR Tablet Urology 2025 Launch
IR Tablet Corticosteroid 2025 Launch
IR Tablet NSAID 2025 Launch
IR Tablet NSAID 2025 Launch
Sterile Opthalmic Ointment Anticholinergic 2025 Launch
Sterile Opthalmic Solution Anticholinergic 2025 Launch
Oral Solution Antibiotic 2025 Launch
IR Capsule Gallstone Dissolution Agent 2025 Launch
IR Tablet Muscle Relaxant/NSAID 2025 Launch
IR Tablet Muscle Relaxant/NSAID 2025 Launch
IR Tablet Antihistamine 2025 Launch
Sterile Injectable Oxidation-Reduction Agent 2025 Launch
IR Tablet NSAID 2025 Launch
IR Tablet Antihistamine 2025 Launch
ODT Tablet Muscle Relaxant 2026 Launch
ODT Tablet NSAID 2026 Launch
ODT Tablet Antihistamine 2026 Launch
Sterile Opthalmic Ointment Antiviral 2026 Launch
On Market Category Type
Ergomar Migraine Relief Commercial
Florafol Pediatric Vitamin Commercial
Florafol FE Pediatric Vitamin Commercial
Selenious Acid Injection IV Supplement Commercial
On Market Category Type
Phenobarbital Sodium Injection Barbiturate Partner
Tetracaine HCl Injection Neuronal Membrane Stabilizer Partner
Diclofenac Potassium Tablet NSAID Partner
Cataflam Pain Relief Partner
Lofena NSAID Partner
Papaverine Injection ED Partner
On Market Category Type
IR Tablet Urology 2025 Launch
IR Tablet Corticosteroid 2025 Launch
IR Tablet NSAID 2025 Launch
IR Tablet NSAID 2025 Launch
Sterile Opthalmic Ointment Anticholinergic 2025 Launch
Sterile Opthalmic Solution Anticholinergic 2025 Launch
Oral Solution Antibiotic 2025 Launch
IR Capsule Gallstone Dissolution Agent 2025 Launch
IR Tablet Muscle Relaxant/NSAID 2025 Launch
IR Tablet Muscle Relaxant/NSAID 2025 Launch
IR Tablet Antihistamine 2025 Launch
Sterile Injectable Oxidation-Reduction Agent 2025 Launch
IR Tablet NSAID 2025 Launch
IR Tablet Antihistamine 2025 Launch
ODT Tablet Muscle Relaxant 2026 Launch
ODT Tablet NSAID 2026 Launch
ODT Tablet Antihistamine 2026 Launch
Sterile Opthalmic Ointment Antiviral 2026 Launch